Oct 2026· Clinical pharmacology and therapy· 0 citations· 8 references
Medicine
TL;DR
This work proposes a framework using genotype-stratified trials to characterize pharmacogenetic sources of variability, informing MIDD and MPID models while helping identify additional determinants of therapeutic response in CMC.
Abstract
Model-informed drug development (MIDD) and model-informed precision dosing (MIPD) increasingly guide drug development, regulatory decision-making, and individualized therapy but rely on robust data. Current models inadequately represent children with medical complexity (CMC), whose unique physiology, comorbidities, and polypharmacy contribute to substantial variability in drug exposure and response. We propose a framework using genotype-stratified trials to characterize pharmacogenetic sources of variability, informing MIDD and MPID models while helping identify additional determinants of therapeutic response in CMC.
Personalized cancer treatment requires stratification of patients based on biomarkers. Despite advances in biomarker-guided therapy, biomarkers are not always available or sufficient to predict treatment responses in individual patients. Functional ex vivo cancer models with the potential to assess therapeutic outcomes...
Eveline C. Smit, Zofia M. Komar, H. Blommestein et al.· Trends in Cancer· 0 citations
Specific laboratory practices that should be discontinued or established and followed as standard practice are proposed and ideal practices that would advance pharmacogenomics in clinical care are proposed.
E. Fieg, Benjamin Kerman, Lucas A. Berenbrok et al.· Clinical pharmacology and th...· 0 citations
Clozapine remains the most effective treatment for treatment-resistant schizophrenia, yet its use is constrained by concerns about safety and preventable adverse outcomes. Evidence on clozapine safety remains fragmented and methodologically heterogeneous, limiting translation into clinical practice. Pharmacovigilance,...
Precision medicine is an approach to tailoring disease prevention and treatment based on individual patient characteristics, aiming to deliver the right treatment to the right patient at the right time. Precision dosing relies on clinical tools capable of integrating genotypic and phenotypic characteristics to inform i...
Give the same dose of the same drug to two patients, and one may be cured while the other is harmed—a problem as old as prescribing itself. Much of that variability is written in the genome. Pharmacogenetics, the study of how inherited variation modifies drug response, has matured from a laboratory curiosity into a...
J. Sikarwar, Zunaira Amber, Nada Mohamme et al.· International Journal For Mu...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.